Stories by David Hoffer, Bas Van Der Brugge and Malorye A. Branca

Over the rainbow yet?

FRAMINGHAM (11/24/2003) - The optimists who've been chanting "It can't get any worse" are finally sounding smart. A number of signs point to brighter times for biotech companies, including rumored imminent IPOs becoming more than pipe dreams. In fact, Acusphere Inc. recently completed the first biotech offering since June 2002, according to VentureWire editor Ken Andersen, and more are lined up to go.